Inhibitory effects of eutigosides isolated from Eurya emarginata on the inflammatory mediators in RAW264.7 cells

Archives of Pharmacal Research

Volumn 28, Issue 11, 2005, Pages 1244-1250

  Park, Soo Yeong ^d   Lee, Hye Ja ^a   Yoon, Weon Jong ^a   Kang, Gyoung Jin ^a   Moon, Ji Young ^b   Lee, Nam Ho ^b   Kim, Se Jae ^c   Kang, Hee Kyoung ^a   Yoo, Eun Sook ^a,e  

^a Department of Advanced Organic Materials Science and Engineering   (South Korea)

^b Department of Aquatic Life Medicine   (South Korea)

^c Jeju National University   (South Korea)

^d Biodiversity Research Institute   (South Korea)

^e Jeju National University School of Medicine   (South Korea)

Author keywords

COX 2; Eutigoside B; Eutigoside C; iNOS; Pro inflammatory cytokines

Indexed keywords

EID: 28844504456     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02978207     Document Type: Article

References (41)

1. Axtelle, T. and Pribble, J., IC14, a CD14 specific monoclonal antibody is a potential treatment for patients with severe sepsis. J. Endotoxin Res., 7, 3599-3605 (2001).
2. Boraschi D., Cifone, M. G., Falk, W., Flad, H. -D., Tagliabue, A., and Martin, M. U., Cytokines in inflammation. Eur. Cytokine Netw., 9, 205-212 (1998).
3. Cho, J. Y., Park, J., Yoo, E. S., Baik, K. U., Lee J., and Park, M. H., Inhibitory effect of sesquiterpene lactones from Saussurea lappa on tumor necrosis factor-α production in murine macrophage-like cell. Planta Med., 64, 594-597 (1998).
4. Chung, M. G. and Epperson, B. K., Clonal and spatial genetic structure in Eurya emarginata (Theaceae). Heredity., 84, 170-177 (2000).
5. Diaz, A., Reginato, A. M., and Jimenez, S. A., Protein, nucleotide alternative splicing of human prostaglandin G/H synthase mRNA and evidence of differential regulation of the resulting transcripts by transforming growth factor beta 1,interleukin 1 beta, and tumor necrosis factor-alpha. J. Biol. Chem., 267, 10816-10822 (1992).
6. Dinarello, C. A., Pro-inflammatory cytokines. Chest., 118, 503-508 (2000).
7. Grisham, M. B., Granger, D. N., and Lefer, D. J., Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radical Biol. Med., 25, 404-433 (1998).
8. Hawkey, C. J., COX-2 inhibitors. Lancet, 353, 307-314 (1999).
9. Henderson, B., Poole, S., and Wilson, M., Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev., 60, 316-341 (1996).
10. Henkel, T., Machleidt, T., Alkalay, I., Kronke, M., Ben-Neriah, Y., and Baeuerle, P. A., Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature, 365, 182-185 (1993).
11. Hersh, D., Weiss, J., and Zychlinsky, A., How bacteria initiate inflammation: aspects of the emerging story. Curr. Opin. Microbiol., 1, 43-48 (1998).
12. Hla, T. and Neilson, K., Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. U.S.A., 89, 7384-7388 (1992).
13. Holloway, A. F., Rao, S., and Shannon, M. F., Regulation of cytokine gene transcription in the immune system. Mol. Immunol., 38, 567-580 (2002).
14. Khan, I. A., Erdelmeier, C. A. J., and Sticher, O., New phenolic glucosides from the leaves of Eurya tigang. J. Nat. Prod., 55, 1270-1274 (1992).
15. Lazarov, S., Balutsov, M., and Ianev, E., The role of bacterial endotoxins, receptors and cytokines in the pathogenesis of septic(endotoxin) shock. Vutr. Boles., 32, 33-40 (2000).
16. Lerner, U. H. and Modeer, T., Bradykinin B1 and B2 receptor agonists synergistically potentiate interleukin-1 induced prostaglandin biosynthesis in human gingival fibroblasts. Inflammation., 15, 427-436 (1991).
17. MacMicking, J., Xie, Q. W., and Nathan, C., Nitric oxide and macrophage function. Annu. Rev. Immunol., 15, 323-350 (1997).
18. Marletta, M. A., Yoon, P. S., Iyengar, R., Life, C. D., and Wishnok, J. S., Oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry, 27, 8706-8711 (1988).
19. Marin, J. and Rodriguez-Martinez, M. A., Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol. Therap., 75, 111-134 (1997).
20. Moncada, S., Palmer, R. M., and Higgs, E. A., Nitric oxide: physiology, pathophysiology. Pharmacol. Rev., 43, 109-142 (1992).
21. Mukaida, N., Ishikawa, Y., Ikeda, N., Fujioka, N., Watanabe, S., Kuno, K., and Matsushima, K., Novel insight into molecular mechanism of endotoxin shock; biochemical analysis of LPS receptor signaling in a cell-free system targeting NF-kapperB and regulation of cytokine production/action through beta2 integrin in vivo. J. Leukoc. Biol., 59, 145-151 (1996)
22. Nathan, C. and Xie, Q. W., Nitric oxide synthases: roles, tolls and controls. Cell, 78, 915-918 (1994).
23. Needleman, P. and Isakson, P. C., Selective inhibition of cyclooxygenase 2. Sci. Med., 1, 35-36 (1998).
24. Nicod, L. P., Cytokines: overview. Thorax, 48, 660-667 (1993).
25. Oppenheim, J. J., Cytokines: past, present, and future. Int. J. Hematol., 74, 38 (2001).
26. O'Sullivan, M. G., Chilton, F. H., Huggins, E. M. Jr., and McCall C. E., Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J. Biological. Chem., 267, 14547-14550 (1992).
27. Perry, E. K., Pickering, A. T., Wang, W. W., Houghton, P. J., and Perru, N. S., Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy. J. Pharm. Pharmacol., 51, 527-534 (1999).
28. Repetto, M. G. and Llesuy, S. F., Antioxidant properties of natural compounds used in popular medicine for gastric ulcers. Braz. J. Med. Biol. Res., 35, 523-534 (2002).
29. Rosselli, M., Keller, P. J., and Dubey, R. K., Role of nitric oxide in the biology, physiology and pathophysiology of reproduction. Hum. Reprod. Update., 4, 3-24 (1998).
30. Ryu, S. Y., Oak, M. H., Yoon, S. K., Cho, D. I., Yoo, G. S., Kim, T. S., and Kim, K. M., Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Medica, 66, 358-360 (2000).
31. Rouveix, B., Clinical pharmacology of cytokines. Eur. Cytokine Netw., 8, 291-293 (1997).
32. Sambrook, J. E., Fritsch, F., and Maniatis, T., In Molecular Cloning Laboratory Manual (2nd ed.), Cold Spring Harbor Laboratory Press, United States of America. 7-8 (1989).
33. Schutt, C. and Schumann, R., The endotoxin recepter CD14. Immun. Infekt., 21, 36-40 (1993).
34. Scott, M. G. and Hancock, R. E., Cationic antimicrobial peptides and their imultifunctional role in the immune system. Crit. Rev. Immunol., 20, 407-431 (2000).
35. Smith, W. L. and Marnett, L. J., Prostaglandin endoperoxide synthase: structure and catalysis. Biochem. Biophys. Acta, 1083, 1-17 (1991).
36. Stein, B. and Sutherland, M. S. K., IL-6 as a drug discovery target. Drug Discov. Today, 3, 202-213 (1998).
37. Turcanu, V. and Williams, N. A., Cell identification and isolation on the basis of cytokine secretion: a novel tool for investigating immune responses. Nat. Med., 7, 373-376 (2001).
38. Ulevitch, R. J. and Tobias, P. S., Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol., 13, 437-457 (1995).
39. Vane, J. R., Bakhle, Y. S., and Botting, R. M.. Cyclooxygenases 1 and 2. Annual Rev. Pharmacol. Toxicol., 38, 97-120 (1998).
40. Wei, X. C. and Smith, I. G., Altered immune response in mice lacking inducible nitric oxide synthetase. Nature, 375, 408-411 (1995).
41. Xie, Q. W., Kashiwabara, Y., and Nathan, C., Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem., 69, 4705-4708 (1994).